Accurate prediction of CRISPR editing outcomes in somatic cell lines and zygote with few-shot learning

The CRISPR-Cas system has revolutionized gene editing, while its outcome prediction remains unsatisfactory, especially in new cell states due to their distinct DNA repair preferences. In this study, we introduce inDecay, a flexible system for predicting CRISPR editing outcomes from target sequence, returning probabilities of nearly the full spectrum of indel events. Uniquely, inDecay utilizes informative and parameter-efficient features for each indel event and incorporates cell-type-specific repair preferences through a multi-stage design. While both inDecay and existing methods achieve accurate results for prediction within cell lines, only inDecay with transfer learning can retain the high performance for cross-cell line prediction. We then applied inDecay to mouse embryo editing using our newly generated data and observed remarkable accuracy by including as few as 30 fine-tuning embryonic samples. Notably, inDecay is the first software to predict embryonic editing. Therefore, our few-shot learning-supported system may accelerate guide RNA prioritization in mouse model generation, mammal embryonic gene editing, and cellular therapeutics.